Xenetic Biosciences, Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update Aug 14, 2024
Xenetic Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update May 10, 2024
Xenetic Biosciences, Inc. Enters into Research Agreement with the University of Virginia for the Advancement of its DNase-Based Oncology Platform Jan 17, 2024
Xenetic Biosciences, Inc. to Present at the H.C. Wainwright 25th Annual Global Investment Conference Sep 5, 2023